Faraz Ali, Chief Executive Officer at Tenaya Therapeutics, Inc. (TNYA), sold 22,232 shares at $0.71 ($16K) on 2026-08-17, disclosed to the SEC on 2026-08-17.
Seasonal sale ($16k) by Chief Executive Officer — this insider has traded TNYA in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 5,020 | $4K | 22.6% |
| 2 | $0.71 | 5,837 | $4K | 26.3% |
| 3 | $0.71 | 7,406 | $5K | 33.3% |
| 4 | $0.71 | 3,969 | $3K | 17.9% |
| Total | $0.71 avg | 22,232 | $16K | 100% |
| Filing → |
| TNYA | SELL | 2025-11-17 | $4K | — | Filing → |
| TNYA | SELL | 2025-08-18 | $18K | — | Filing → |
| TNYA | SELL | 2025-05-16 | $1K | — | Filing → |